WAGENHEIM PHILIP
SEC Form 4 insider trading activity
WAGENHEIM PHILIP has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including SWMR, IMNM, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, WAGENHEIM PHILIP is listed as Director at Immunome Inc. Inside the rolling window, WAGENHEIM PHILIP reported no open-market purchases and 2 open-market sales totaling $1.3M in IMNM. The largest disclosed transaction in the window is a sale of 36,800 IMNM shares on Mar 20, 2026, worth $753K.
Companies traded
Other insiders at SWMR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WAGENHEIM PHILIP made?
WAGENHEIM PHILIP has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including SWMR, IMNM since 2026.
Which companies does WAGENHEIM PHILIP trade?
WAGENHEIM PHILIP has filed SEC Form 4 disclosures for 2 companies, including SWMR, IMNM.
When was WAGENHEIM PHILIP's most recent SEC Form 4 filing?
WAGENHEIM PHILIP's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is WAGENHEIM PHILIP's total buy and sell value in the current window?
Inside the rolling retention window, WAGENHEIM PHILIP bought $0 and sold $1.3M based on SEC Form 4 filings.
What was WAGENHEIM PHILIP's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,800 IMNM shares on 2026-03-20, worth $753K, per SEC Form 4 filings.